文献速递消化道肿瘤放疗放疗物理与技术

直肠癌磁共振引导自适应放疗的剂量追踪评估

Dose tracking assessment for magnetic resonance guided adaptive radiotherapy of rectal cancers.
PubMed 文献 · Radiat Oncol · 2024-09-02

本研究回顾性纳入19例接受1.5特斯拉磁共振直线加速器短程放疗(处方剂量25 Gy,5 Gy×5)的直肠癌患者,比较磁共振引导自适应放疗(MRgART)与模拟的常规影像引导放疗(IGRT)的剂量学差异。MRgART所有分次均满足靶区临床要求,而IGRT有67.0%(63/94)分次未达到预期靶区覆盖。作者认为MRgART可确保每分次剂量与计划一致,剂量累积过程似乎冗余;IGRT可能导致靶区剂量偏差和危及器官约束不达标。

要点

  • MRgART所有95个分次均满足靶区临床要求,IGRT有67.0%(63/94)分次未达到预期靶区覆盖。
  • 膀胱中位[公式]值自适应分次为18.18 Gy,IGRT分次为19.60 Gy;小肠分别为23.40 Gy和25.69 Gy。
  • 作者认为MRgART剂量累积过程似乎冗余,而IGRT剂量累积仍能显示显著剂量学差异。

核心结论

  • 直肠癌短程放疗中,MRgART确保所交付剂量与每个分次的计划剂量匹配,且剂量累积过程证实了这一点,因此该过程似乎冗余。
  • 相比之下,IGRT可能导致靶区剂量偏差和危及器官约束不达标,剂量累积仍能显示显著的剂量学差异。

研究设计与样本

  • 回顾性研究纳入19例接受1.5特斯拉磁共振直线加速器短程放疗的直肠癌患者,处方剂量25 Gy(5 Gy×5),基于在线磁共振合成CT(sCT)图像进行每日自适应计划优化。
  • 对每个自适应计划,将参考CT计划在刚性配准后重算至每日磁共振sCT图像上生成第二计划,以模拟IGRT工作流程。
  • 比较每个分次两种工作流程的剂量学,并评估首分次和末分次的累积剂量,采用剂量体积直方图参数进行比较。

主要发现

  • 共比较95个MRgART分次与对应的模拟IGRT分次;MRgART所有分次均满足靶区临床要求。
  • IGRT有63/94分次(67.0%)未达到预期靶区覆盖,其中13个分次V95中位点百分比下降2.78%(范围1.65-4.16%),55个分次超过V107%阈值,中位值15.4 cc(范围6.0-43.8 cc)。
  • 膀胱中位[公式]值自适应分次为18.18 Gy,IGRT分次为19.60 Gy;小肠中位[公式]值分别为23.40 Gy和25.69 Gy。
  • 自适应工作流程首分次或末分次累积剂量未见统计学显著差异,结果与单次自适应分次一致。
  • IGRT工作流程累积剂量显示显著变化,减轻了高剂量约束,但仍有超过一半的患者未满足临床要求。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Magnetic resonance-guided adaptive radiotherapy (MRgART) at MR-Linac allows for plan optimisation on the MR-based synthetic CT (sCT) images, adjusting the target and organs at risk according to the patient's daily anatomy. Conversely, conventional linac image-guided radiotherapy (IGRT) involves rigid realignment of regions of interest to the daily anatomy, followed by the delivery of the reference computed tomography (CT) plan. This study aims to evaluate the effectiveness of MRgART versus IGRT for rectal cancer patients undergoing short-course radiotherapy, while also assessing the dose accumulation process to support the findings and determine its usefulness in enhancing treatment accuracy. METHODS: Nineteen rectal cancer patients treated with a 1.5 Tesla MR-Linac with a prescription dose of 25 Gy (5 Gy x 5) and undergoing daily adapted radiotherapy by plan optimization based on online MR-based sCT images, were included in this retrospective study. For each adapted plan ([Formula: see text]), a second plan ([Formula: see text]) was generated by recalculating the reference CT plan on the daily MR-based sCT images after rigid registration with the reference CT images to simulate the IGRT workflow. Dosimetry of [Formula: see text] and[Formula: see text]was compared for each fraction. Cumulative doses on the first and last fractions were evaluated for both workflows. The dosimetry per single fraction and the cumulative doses were compared using dose-volume histogram parameters. RESULTS: Ninety-five fractions delivered with MRgART were compared to corresponding simulated IGRT fractions. All MRgART fractions fulfilled the target clinical requirements. IGRT treatments did not meet the expected target coverage for 63 out of 94 fractions (67.0%), with 13 fractions showing a V95 median point percentage decrease of 2.78% (range, 1.65-4.16%), and 55 fractions exceeding the V107% threshold with a median value of 15.4 cc (range, 6.0-43.8 cc). For the bladder, the median [Formula: see text] values were 18.18 Gy for the adaptive fractions and 19.60 Gy for the IGRT fractions. Similarly the median [Formula: see text] values for the small bowel were 23.40 Gy and 25.69 Gy, respectively. No statistically significant differences were observed in the doses accumulated on the first or last fraction for the adaptive workflow, with results consistent with the single adaptive fractions. In contrast, accumulated doses in the IGRT workflow showed significant variations mitigating the high dose constraint, nevertheless, more than half of the patients still did not meet clinical requirements. CONCLUSIONS: MRgART for short-course rectal cancer treatments ensures that the dose delivered matches each fraction of the planned dose and the results are confirmed by the dose accumulation process, which therefore seems redundant. In contrast, IGRT may lead to target dose discrepancies and non-compliance with organs at risk constraints and dose accumulation can still highlight notable dosimetric differences.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Xin X, Tang B, Wu F, et al. Dose tracking assessment for magnetic resonance guided adaptive radiotherapy of rectal cancers. Radiat Oncol. 2024. PMID: 39218934. doi:10.1186/s13014-024-02508-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。